H-1B filings

Does Vanda Pharmaceuticals Inc. sponsor H-1B?

Yes, according to public filings. Vanda Pharmaceuticals Inc. filed 15 H-1B labor condition applications in fiscal years 2024-2026, including 3 in fiscal year 2026.

USCIS approved 14 H-1B petitions for this employer in fiscal years 2024-2026.

This page uses public government filings. A filing does not guarantee that the employer will sponsor you. This information is not legal advice.

Status on October 22, 2026: USCIS does not collect the $100,000 payment on new H-1B petitions for workers outside the U.S. while court orders stand. Appeals are pending, so this can change. USCIS H-1B FAQ

Labor condition applications by fiscal year

Fiscal yearFiledCertifiedWorkers
2026333
2025555
2024777

An employer files a labor condition application with the Department of Labor before it files an H-1B petition. A certified application is not an approved visa. The U.S. fiscal year runs from October 1 to September 30.

USCIS decisions on H-1B petitions by fiscal year

Fiscal yearNew: approvedNew: deniedContinuing: approvedContinuing: denied
20260030
20252030
20240060

New petitions are for first H-1B employment. Continuing petitions are for extensions and for workers who change employers.

Typical roles and wage ranges

Job titleApplicationsWage range per yearMedian
Clinical Data Manager3$85,000 - $100,000$100,000
Bioinformatics Scientist2$145,000 - $170,000$170,000
Sr. Software Engineer2$170,000 - $170,000$170,000
Sr. Statistical Analyst2$110,000 - $120,000$120,000
Director Biostatistics1$230,000 - $230,000$230,000
Data Engineer1$100,000 - $100,000$100,000
Statistical Analyst1$105,000 - $105,000$105,000
Manager, QA/Cmc Regulatory1$119,000 - $119,000$119,000
Senior Scientist, Analytical Chemistry1$125,000 - $125,000$125,000
Manager, Statistical Programming1$130,000 - $130,000$130,000

Wages are the rates the employer stated in its applications. Actual pay can differ.

Top locations

LocationApplications
Washington, DC14
Washington, D.C., DC1

Sources

Data release 2026q3, built on October 23, 2026.